Dean Schauer takes leadership as chairman at Confluent Medical Technologies

On September 11, 2024, Confluent Medical Technologies announced that Dean Schauer has taken on the role of Chairman of the Board while continuing his responsibilities as CEO and President. Schauer, who has led the company for over a decade, expressed gratitude for the trust placed in him by investors and employees. He emphasized the importance of innovation and excellence that has driven the company's growth during his tenure. Under Schauer's leadership, Confluent has significantly increased its revenue and established itself as a leader in the medical technology sector. The company has focused on enhancing its materials sciences capabilities and expanding customer partnerships, which are crucial for meeting the evolving needs of clients in the industry. Schauer's vision includes increasing investments to support a seamless supply chain, which is vital for delivering value to partners and patients. The appointment of Schauer as Chairman aligns with Confluent's strategic efforts to strengthen its leadership and operations. Earlier in March, the company welcomed two experienced executives, Sandy Stojkovski and Brian Yoor, to its board, further enhancing its operational and financial expertise. This move reflects Confluent's commitment to adapting to the growing demands of the market. Industry experts, including Kendall Garrison and John Schilling from TPG, expressed confidence in Schauer's expanded role, highlighting his successful track record and the company's potential for continued growth. This leadership transition marks a significant step in Confluent's journey as it aims to maintain its status as a trusted partner to OEMs worldwide.